Published in Int J Cancer on August 29, 2013
Panorama from the oncolytic virotherapy summit. Mol Ther (2013) 0.81
Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer. Surgery (2015) 0.79
Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses. Oncolytic Virother (2013) 0.77
Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis. Surgery (2015) 0.76
Molecular imaging of oncolytic viral therapy. Mol Ther Oncolytics (2015) 0.76
Targeting tumor vasculature through oncolytic virotherapy: recent advances. Oncolytic Virother (2015) 0.75
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell (2009) 6.77
Beta oscillations in a large-scale sensorimotor cortical network: directional influences revealed by Granger causality. Proc Natl Acad Sci U S A (2004) 5.51
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J (2005) 3.79
Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum (2002) 3.78
A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J Bacteriol (2002) 3.55
The targeted oncolytic poxvirus JX-594 demonstrates antitumoral, antivascular, and anti-HBV activities in patients with hepatocellular carcinoma. Mol Ther (2008) 2.72
Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans. J Bacteriol (2002) 2.62
Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet (2010) 2.51
Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963. J Clin Invest (2007) 2.36
Neuronal mechanisms of cortical alpha oscillations in awake-behaving macaques. J Neurosci (2008) 2.21
Incidence of breast cancer and its subtypes in relation to individual and multiple low-penetrance genetic susceptibility loci. JAMA (2010) 2.20
Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus. PLoS Med (2007) 2.15
Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. Mol Ther (2007) 2.14
Ultrasensitive detection of rare mutations using next-generation targeted resequencing. Nucleic Acids Res (2011) 2.11
Global chronic diseases. Science (2005) 1.86
Hypoxia promotes ligand-independent EGF receptor signaling via hypoxia-inducible factor-mediated upregulation of caveolin-1. Proc Natl Acad Sci U S A (2012) 1.80
Is partial coherence a viable technique for identifying generators of neural oscillations? Biol Cybern (2004) 1.70
Intelligent design: combination therapy with oncolytic viruses. Mol Ther (2009) 1.68
Ischemic insults direct glutamate receptor subunit 2-lacking AMPA receptors to synaptic sites. J Neurosci (2006) 1.63
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans. Cancer Res (2013) 1.55
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide. Clin Cancer Res (2009) 1.53
Synergistic interaction between oncolytic viruses augments tumor killing. Mol Ther (2010) 1.51
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin. Cancer Res (2007) 1.50
Granger causality between multiple interdependent neurobiological time series: blockwise versus pairwise methods. Int J Neural Syst (2007) 1.37
Direct-current electrical field guides neuronal stem/progenitor cell migration. Stem Cells (2008) 1.34
Housekeeping genes; expression levels may change with density of cultured cells. J Immunol Methods (2010) 1.32
Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci (2004) 1.28
Prestimulus cortical activity is correlated with speed of visuomotor processing. J Cogn Neurosci (2008) 1.25
The global alliance for chronic diseases. Science (2009) 1.23
Identification of genetically modified Maraba virus as an oncolytic rhabdovirus. Mol Ther (2010) 1.22
Patellofemoral realignment: dynamic intraoperative assessment. Iowa Orthop J (2005) 1.21
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotide. Mol Ther (2004) 1.21
Estimating Granger causality after stimulus onset: a cautionary note. Neuroimage (2008) 1.19
Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene (2004) 1.19
The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp Cell Res (2011) 1.12
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women. Breast J (2012) 1.12
Multiple kernel learning in protein-protein interaction extraction from biomedical literature. Artif Intell Med (2011) 1.10
VSV oncolysis in combination with the BCL-2 inhibitor obatoclax overcomes apoptosis resistance in chronic lymphocytic leukemia. Mol Ther (2010) 1.08
Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin. Cancer Res (2010) 1.08
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J Virol (2009) 1.06
A call to reform the taxonomy of human disease. Nat Rev Drug Discov (2011) 1.06
Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. J Neurotrauma (2007) 1.06
Pulmonary formulations: what remains to be done? J Aerosol Med Pulm Drug Deliv (2010) 1.05
Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved (2009) 1.05
Analyzing brain networks with PCA and conditional Granger causality. Hum Brain Mapp (2009) 1.04
High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Lett (2006) 1.03
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine. Mol Ther (2012) 1.03
Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice. Cancer Res (2010) 1.03
Cortical functional network organization from autoregressive modeling of local field potential oscillations. Stat Med (2007) 1.03
Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis. J Virol (2008) 1.02
Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen. Mol Biol Cell (2005) 0.99
Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo. Cancer Res (2004) 0.98
Images in cardiothoracic surgery. Pleuroperitoneal fistula. Ann Thorac Surg (2002) 0.98
Social workers as patient navigators for breast cancer survivors: what do African-American medically underserved women think of this idea? Soc Work Health Care (2009) 0.97
Bax-dependent mitochondrial membrane permeabilization enhances IRF3-mediated innate immune response during VSV infection. Virology (2007) 0.97
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice. PLoS One (2010) 0.97
Essential role of RGS-PX1/sorting nexin 13 in mouse development and regulation of endocytosis dynamics. Proc Natl Acad Sci U S A (2006) 0.96
A tumorigenic MLL-homeobox network in human glioblastoma stem cells. Cancer Res (2012) 0.96
Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structures. World J Surg (2003) 0.96
Detecting directional influence in fMRI connectivity analysis using PCA based Granger causality. Brain Res (2009) 0.95
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. PLoS One (2010) 0.95
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primates. Hum Gene Ther (2006) 0.95
Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses. Trends Mol Med (2013) 0.95
Propagation, purification, and in vivo testing of oncolytic vesicular stomatitis virus strains. Methods Mol Biol (2012) 0.94
Spoligotyping of Mycobacterium bovis isolates found in Manitoba. Can J Vet Res (2005) 0.94
Vesicular stomatitis virus oncolysis of T lymphocytes requires cell cycle entry and translation initiation. J Virol (2008) 0.93
MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway. Liver Int (2014) 0.92
Intratracheal and oral administration of SM-276001: a selective TLR7 agonist, leads to antitumor efficacy in primary and metastatic models of cancer. Int J Cancer (2012) 0.92
Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects. Mol Cell Biol (2005) 0.91
Enhancing photoactivity of TiO2(B)/anatase core-shell nanofibers by selectively doping cerium ions into the TiO2(B) core. Chemistry (2013) 0.91
Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience. Breast J (2015) 0.90
A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword. Adv Healthc Mater (2012) 0.90
In vivo optical imaging of tumor and microvascular response to ionizing radiation. PLoS One (2012) 0.90
Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv (2010) 0.90
Circadian regulation of GABAA receptor function by CKI epsilon-CKI delta in the rat suprachiasmatic nuclei. Nat Neurosci (2004) 0.89
Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates. Hum Gene Ther (2011) 0.88
Involvement of Wnt signaling in the injury of murine mesenchymal stem cells exposed to X-radiation. Int J Radiat Biol (2012) 0.88
Oncolytic vaccinia virus as an adjuvant treatment to cytoreductive surgery for malignant peritoneal mesothelioma. Ann Surg Oncol (2014) 0.87
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin. Neuro Oncol (2013) 0.87
Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors. Mol Oncol (2013) 0.87
Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol (2010) 0.86
Beyond structure, to survival: activation of Stat3 by cadherin engagement. Biochem Cell Biol (2009) 0.86
Oncolytic viruses: an approved product on the horizon? Mol Ther (2010) 0.86
Ranking support vector machine for multiple kernels output combination in protein-protein interaction extraction from biomedical literature. Proteomics (2011) 0.86
Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol Ther (2012) 0.86
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2. Mol Ther (2008) 0.86
Reduced electron recombination of dye-sensitized solar cells based on TiO(2) spheres consisting of ultrathin nanosheets with [001] facet exposed. Beilstein J Nanotechnol (2012) 0.85
A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation. Biol Blood Marrow Transplant (2007) 0.85
Stat3 activity is required for gap junctional permeability in normal rat liver epithelial cells. DNA Cell Biol (2009) 0.85